Context Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	66	94.43	14.45	35.5	49.64
Cash & Short-Term Investments	66	94.43	14.45	35.5	49.64
Cash Growth	-30.11%	553.50%	-59.29%	-28.48%	16976.13%
Other Current Assets	2.36	3.47	1.6	2.36	1.62
Total Current Assets	68.35	97.9	16.05	37.85	51.26
Net Property, Plant & Equipment	0.14	0.23	0.02	0.08	-
Other Long-Term Assets	-	-	-	0.03	0.05
Total Assets	68.49	98.13	16.06	37.97	51.31
Accounts Payable	2.53	1.45	2.38	0.94	1.83
Accrued Expenses	5.38	1.19	1.81	2.22	1.21
Current Portion of Leases	0.11	0.11	-	0.06	-
Total Current Liabilities	8.02	2.75	4.19	3.21	3.03
Long-Term Leases	-	0.11	-	-	-
Total Long-Term Liabilities	-	0.11	-	-	-
Total Liabilities	8.02	2.86	4.19	3.21	3.03
Common Stock	0.09	0.09	0.02	0.02	0.02
Additional Paid-in Capital	191.29	189.96	79.91	78.83	77.51
Retained Earnings	-130.9	-94.78	-68.05	-44.09	-29.25
Total Common Shareholders' Equity	60.47	95.27	11.87	34.76	48.27
Shareholders' Equity	60.47	95.27	11.87	34.76	48.27
Total Liabilities & Equity	68.49	98.13	16.06	37.97	51.31
Total Debt	0.11	0.22	0	0.06	0
Net Cash (Debt)	65.88	94.21	14.45	35.44	49.64
Net Cash Growth	-30.07%	551.98%	-59.23%	-28.59%	-
Net Cash Per Share	0.69	1.61	0.91	2.22	17.52
Book Value	60.47	95.27	11.87	34.76	48.27
Book Value Per Share	0.64	1.63	0.74	2.18	17.04
Tangible Book Value	60.47	95.27	11.87	34.76	48.27
Tangible Book Value Per Share	0.64	1.63	0.74	2.18	17.04

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q